Disease

2026 MLO State of the Industry Survey: Laboratories navigate antimicrobial resistance challenges, shifting respiratory testing trends, and ongoing supply chain pressures

The 2026 Medical Laboratory Observer (MLO) State of the Industry (SOI) Survey on Disease Management focused on antimicrobial resistance (AMR) and respiratory testing. MLO asked...

Aug. 4, 2026

Cancer

Alcohol use as a modifiable risk factor for cancer: New insights from Miami research

Sept. 4, 2026

Infectious Disease

WHO and Africa CDC declare end of Ebola outbreak in Uganda after 42 days without new cases

Sept. 4, 2026

Antibiotic Resistance

AI-driven bacteriophage development targets resistant E. coli strains

Sept. 2, 2026

Disease

Labcorp introduces hepatitis D reflex testing

Sept. 2, 2026

Cancer

Blood cancer patients may have more transplant options, study finds

Aug. 25, 2026

Disease

Study confirms MBCT does not increase depression relapse risk

Aug. 25, 2026

Biomarkers

Roche announces FDA clearance for Elecsys pTau217

Aug. 25, 2026

Infectious Disease

Literature review reveals financial burden of measles

Aug. 24, 2026

Disease

2026 MLO State of the Industry Survey: Laboratories navigate antimicrobial resistance challenges, shifting respiratory testing trends, and ongoing supply chain pressures

Alcohol use as a modifiable risk factor for cancer: New insights from Miami research

WHO and Africa CDC declare end of Ebola outbreak in Uganda after 42 days without new cases

AI-driven bacteriophage development targets resistant E. coli strains

Labcorp introduces hepatitis D reflex testing

Blood cancer patients may have more transplant options, study finds

Study confirms MBCT does not increase depression relapse risk

Roche announces FDA clearance for Elecsys pTau217

Literature review reveals financial burden of measles

Looking for Something?